Erythropoetin as a novel agent with pleiotropic effects against acute lung injury Sotirios KakavasTheano DemestihaTheodoros Xanthos Review Article 11 November 2010 Pages: 1 - 9
Different effects of tocolytic medication on blood pressure and blood pressure amplification Isabelle FabryPeter De PaepeLuc Van Bortel Clinical Trial 16 November 2010 Pages: 11 - 17
A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects Görkem EskiizmirZafer HirçinHalis Ünlü Special Article 11 November 2010 Pages: 19 - 23
Study of the pharmacokinetics and intragastric pH of rabeprazole given as successive intravenous infusion to healthy Chinese volunteers Yongqing WangYaozong YuanRuihua Shi Pharmacodynamics 26 November 2010 Pages: 25 - 31
Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences Else-Lydia ToverudAnne Kjersti RøiseInger Wabø Pharmacoeconomics Open access 23 November 2010 Pages: 33 - 38
Effects of UDP-glucuronosyltransferase polymorphisms on the pharmacokinetics of ezetimibe in healthy subjects Jung-Woo BaeChang-Ik ChoiSeok-Yong Lee Pharmacogenetics 24 September 2010 Pages: 39 - 45
Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment? Laura MagliuloMarja-Liisa DahlMaria Gabriella Scordo Pharmacogenetics 08 October 2010 Pages: 47 - 54
Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patients Teresa Maria J. P. CarvalhoRicardo de Carvalho CavalliVera Lucia Lanchote Pharmacokinetics and Disposition 17 September 2010 Pages: 55 - 61
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone Oliver KummerFelix HammannStephan Krähenbühl Pharmacokinetics and Disposition 21 September 2010 Pages: 63 - 71
Prevalence of hypothyroidism in Finland—a nationwide prescription study Lauri J. VirtaSeija I. Eskelinen Pharmacoepidemiology and Prescription 31 August 2010 Pages: 73 - 77
The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians Sander D. BorgsteedeChristiaan A. RhodiusMette L. Rurup Pharmacoepidemiology and Prescription Open access 19 September 2010 Pages: 79 - 89
Defining antimicrobial prescribing quality indicators: what is a new prescription? Jos BoestenLuc HaringsTrudy van der Weijden Pharmacoepidemiology and Prescription Open access 13 October 2010 Pages: 91 - 96
Paracetamol orodispersible tablets: a risk for severe poisoning in children? Alessandro CeschiKatharina E. HoferHugo Kupferschmidt Short Communication 23 November 2010 Pages: 97 - 99
Erratum to: Discovery of the nonfunctional CYP2D6*31 allele in Spanish, Puerto Rican, and US Hispanic populations Andrea GaedigkMaria Isidoro-GarcíaSusan Corey Erratum 13 November 2010 Pages: 101 - 101
Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta Liang QiaoXin CuiYongjie Li Letter to the Editors 31 August 2010 Pages: 103 - 104
Benzodiazepine discontinuation among community-dwelling older people: a population-based cohort study J. Simon BellPiia LavikainenSirpa Hartikainen Letter to the Editors 15 September 2010 Pages: 105 - 106
Prescription writing: a lost art? Balakrishnan SadasivamIsabella TopnoRatinder Jhaj Letter to the Editors 21 September 2010 Pages: 107 - 108